| Perioperative Chemo and Pembrolizumab in Gastric Cancer (NCT02918162) | Gulam Manji | 2017-11-25 |
| A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial Virus (NCT03333317) | Janssen Research & Development, LLC | 2017-11-24 |
| Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome (NCT03070574) | Christoph Gasche | 2017-11-24 |
| Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer (NCT02982694) | Vall d'Hebron Institute of Oncology | 2017-11-24 |
| TDCS and Aphasia Therapy in the Chronic Phase After Stroke (NCT03305614) | University Hospital, Ghent | 2017-11-24 |
| Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib) (NCT04264546) | Jiangsu Province Centers for Disease Control and Prevention | 2017-11-24 |
| Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Healthy Volunteers (NCT03417986) | Immungenetics AG | 2017-11-24 |
| A Study of a New Investigational Medicinal Product to Treat Patients with Advanced or Metastatic Solid Tumors (NCT03316638) | Pierre Fabre Medicament | 2017-11-24 |
| Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients (NCT03254966) | Jiangsu HengRui Medicine Co., Ltd. | 2017-11-24 |
| Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma (NCT03236428) | Dana-Farber Cancer Institute | 2017-11-24 |
| Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509) (NCT03141671) | Dana-Farber Cancer Institute | 2017-11-24 |
| Efficacy and Adverse Effects of Prapchompoothaweep Remedy and Loratadine for Treatment in AR Patients (NCT03640273) | Thammasat University | 2017-11-23 |
| Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (NCT03276078) | AstraZeneca | 2017-11-23 |
| Plasmodium Immunotherapy for Advanced Cancers (NCT03375983) | CAS Lamvac Biotech Co., Ltd. | 2017-11-23 |
| Trial of EXenatide in Acute Ischaemic Stroke (NCT03287076) | Neuroscience Trials Australia | 2017-11-23 |
| DCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian Cancer (NCT03657966) | SOTIO a.s. | 2017-11-23 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder (NCT03375203) | Janssen Research & Development, LLC | 2017-11-23 |
| Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients. (NCT03957733) | King Abdullah Medical City | 2017-11-23 |
| Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T Cells Immunomonitoring. (NCT03339661) | University Hospital, Bordeaux | 2017-11-23 |
| A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tumors (NCT03264066) | Hoffmann-La Roche | 2017-11-23 |
| A Combination of Rituximab and Varlilumab Immunotherapy in Patients with B-cell Lymphoma (NCT03307746) | University Hospital Southampton NHS Foundation Trust | 2017-11-23 |
| High-Dose Vitamin D Induction in Optic Neuritis (NCT03302585) | University of Calgary | 2017-11-23 |
| A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis (NCT03347110) | UCB Biopharma SRL | 2017-11-22 |
| Nivolumab in Combination With Chemotherapy, or Nivolumab in Combination With Ipilimumab, in Advanced EGFR-Mutant or ALK-Rearranged NSCLC (NCT03256136) | Massachusetts General Hospital | 2017-11-22 |
| Furosemide and Coarctation Surgery Lung Complications (NCT03364842) | Cairo University | 2017-11-22 |
| Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma (NCT03030261) | Washington University School of Medicine | 2017-11-22 |
| CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy (NCT03356912) | Consorzio Oncotech | 2017-11-22 |
| Fecal Microbiota Transplantation for Refractory IgA Nephropathy (NCT03633864) | Air Force Military Medical University, China | 2017-11-22 |
| A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors (NCT03314935) | Incyte Corporation | 2017-11-21 |
| K-BASKET, TAS-117, PI3K/AKT Gene Aberration (NCT03017521) | Yonsei University | 2017-11-21 |
| PRebiotic to IMprovE Calcium Absorption (NCT03272542) | San Francisco Veterans Affairs Medical Center | 2017-11-21 |
| Allogeneic ABCB5-positive Stem Cells for Treatment of DFU "Malum Perforans" (NCT03267784) | RHEACELL GmbH & Co. KG | 2017-11-21 |
| Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder (NCT03317158) | Noah Hahn, M.D. | 2017-11-21 |
| uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness (NCT03307460) | Rigshospitalet, Denmark | 2017-11-21 |
| Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6 (NCT03310879) | Dana-Farber Cancer Institute | 2017-11-21 |
| A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC (NCT03318562) | Effector Therapeutics | 2017-11-21 |
| Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization (NCT03182166) | Centre Hospitalier Universitaire de Saint Etienne | 2017-11-21 |
| INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies (NCT03277352) | Incyte Biosciences International Sàrl | 2017-11-21 |
| Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population (NCT03336593) | PT Bio Farma | 2017-11-21 |
| Tau Screening Study in Patients With Early Symptomatic AD (NCT03322462) | Avid Radiopharmaceuticals | 2017-11-21 |
| Topical Curcumin for Precancer Cervical Lesions (NCT02944578) | Lisa Flowers | 2017-11-20 |
| Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis (NCT03334006) | RWTH Aachen University | 2017-11-20 |
| A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor (NCT03235544) | Incyte Corporation | 2017-11-20 |
| Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer (NCT03585062) | Zhejiang Provincial People's Hospital | 2017-11-20 |
| Haploidentical and Mismatched Unrelated Donors Hematopoietic Stem Cell Transplant (NCT03250546) | Assistance Publique - Hôpitaux de Paris | 2017-11-20 |
| Effect Of A Locally Delivered Probiotic Sacchraomyces Boulardii In The Management Of Chronic Periodontitis (NCT03516370) | Tatyasaheb Kore Dental College | 2017-11-20 |
| The Effect of Citrus Extract on Gastrointestinal Health (NCT03225261) | Maastricht University Medical Center | 2017-11-20 |
| Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer (NCT03325816) | Georgetown University | 2017-11-20 |
| Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex (NCT03356769) | Peking Union Medical College Hospital | 2017-11-20 |
| Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous Revacept (NCT03312855) | Deutsches Herzzentrum Muenchen | 2017-11-20 |
| Safety and Efficacy Study of an Edible Colonoscopy Preparation (NCT03332485) | Sebela Pharmaceuticals Development LLC | 2017-11-20 |
| Xylitol for Otitis Media (NCT02950311) | Duke University | 2017-11-20 |
| Efficiency of Icotinib in Plasma ctDNA EGFR Mutation-positive Patients Diagnosed With Lung Cancer (NCT03346811) | Betta Pharmaceuticals Co., Ltd. | 2017-11-18 |
| Impact of Grape Consumption on Brain Metabolism and Neuropsychological Performance Over 1 Year (NCT03361410) | University of California, Los Angeles | 2017-11-18 |
| Fecal Microbiota Transplantation for Pancreatitis (NCT02318134) | The First Affiliated Hospital of Nanchang University | 2017-11-18 |
| Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas (NCT02033616) | Aivita Biomedical, Inc. | 2017-11-18 |
| Dose Finding Study of MCI-186 in Acute Ischemic Stroke (NCT03346538) | Shionogi | 2017-11-17 |
| Safety and Effectiveness of EN3835 in the Treatment of EFP in Women (NCT03329989) | Endo USA Inc., a Keenova Therapeutics Company | 2017-11-17 |
| Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma (NCT02724579) | Children's Oncology Group | 2017-11-17 |
| Administration of Kisspeptin in Patients With Hyperprolactinemia (NCT02956447) | Massachusetts General Hospital | 2017-11-17 |
| Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate (NCT03569345) | Merete Haedersdal | 2017-11-17 |
| Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A (NCT03315104) | Emergent BioSolutions | 2017-11-17 |
| Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML) (NCT03303339) | Cardiff Oncology | 2017-11-17 |
| Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer (NCT03359954) | M.D. Anderson Cancer Center | 2017-11-16 |
| ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis (NCT03093259) | Abivax S.A. | 2017-11-16 |
| Biomarker-based Study in R/M SCCHN (NCT03088059) | European Organisation for Research and Treatment of Cancer - EORTC | 2017-11-16 |
| A Multicentre Study on Rifaximin in Post-operative Endoscopic Crohn's Disease Recurrence Prevention (NCT03537157) | Alfasigma S.p.A. | 2017-11-16 |
| Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors (NCT03245151) | Eisai Inc. | 2017-11-16 |
| Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD (NCT03282123) | Resilient Pharmaceuticals | 2017-11-16 |
| Allogeneic ABCB5-positive Stem Cells for Treatment of CVU (NCT03257098) | RHEACELL GmbH & Co. KG | 2017-11-16 |
| A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma (NCT03357952) | Janssen Research & Development, LLC | 2017-11-16 |
| Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria. (NCT03334747) | Novartis Pharmaceuticals | 2017-11-16 |
| Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM) (NCT03340883) | Chinook Therapeutics, Inc. | 2017-11-15 |
| Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer (NCT03300557) | National Cancer Institute (NCI) | 2017-11-15 |
| Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome (NCT03047993) | M.D. Anderson Cancer Center | 2017-11-15 |
| Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstructive Pulmonary Disease (COPD) (NCT03250689) | GlaxoSmithKline | 2017-11-15 |
| Intervention of Engineered Immune Effector T Cells Against Lung Cancer (NCT03353428) | Shenzhen Geno-Immune Medical Institute | 2017-11-15 |
| Avelumab in Refractory Testicular Germ Cell Cancer. (NCT03403777) | National Cancer Institute, Slovakia | 2017-11-15 |
| PSMA PET and MRI in Gynecological Cancers (NCT03302156) | University of Wisconsin, Madison | 2017-11-15 |
| AGN-242428 in the Treatment of Plaque Psoriasis (NCT03339999) | Vitae Pharmaceuticals, Inc. | 2017-11-15 |
| Avelumab in G2-3 NET (NCT03278379) | Sunnybrook Health Sciences Centre | 2017-11-15 |
| Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly (NCT03373903) | Restorbio Inc. | 2017-11-15 |
| Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension (NCT03310580) | Aerie Pharmaceuticals | 2017-11-15 |
| Treatment Evaluation of Acute Stroke for Using in Regenerative Cell Elements (NCT02961504) | Healios K.K. | 2017-11-15 |
| Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma (NCT03325101) | Mayo Clinic | 2017-11-15 |
| Evaluation of DEX-IN During Outpatient Procedures (NCT03348423) | Baudax Bio | 2017-11-15 |
| Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children (NCT03339128) | AbbVie | 2017-11-15 |
| Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) (NCT03222973) | Biogen | 2017-11-15 |
| Decitabine Plus Carboplatin in the Treatment of Metastatic TNBC (NCT03295552) | Shanghai Jiao Tong University School of Medicine | 2017-11-15 |
| Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma (NCT03339349) | University of Utah | 2017-11-15 |
| ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer (NCT03480646) | Constellation Pharmaceuticals | 2017-11-15 |
| Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds (NCT03295318) | Serum Institute of India Pvt. Ltd. | 2017-11-15 |
| NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma (NCT02805894) | Nanobiotix | 2017-11-15 |
| New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques (NCT03335033) | Mayo Clinic | 2017-11-15 |
| Avelumab in G3 NEC (NCT03278405) | Sunnybrook Health Sciences Centre | 2017-11-15 |
| A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence (NCT03194542) | Celgene | 2017-11-15 |
| Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies (NCT03363893) | Carrick Therapeutics Limited | 2017-11-14 |
| Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma (NCT03469934) | AnaptysBio, Inc. | 2017-11-14 |
| A Study of PC786 to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of Multiple Doses in an RSV Challenge Study (NCT03382431) | Pulmocide Ltd | 2017-11-14 |
| Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272) (NCT03123588) | Incyte Corporation | 2017-11-14 |